Error
Jump to navigation
Jump to search
Pages in category "Biological weapons"
The following 185 pages are in this category, out of 185 total.
A
- Anthrax
- Anthrax chest x ray
- Anthrax cost-effectiveness of therapy
- Anthrax CT
- Anthrax differential diagnosis
- Anthrax epidemiology and demographics
- Anthrax future or investigational therapies
- Anthrax historical perspective
- Anthrax history and symptoms
- Anthrax laboratory findings
- Anthrax medical therapy
- Anthrax natural history, complications and prognosis
- Anthrax other diagnostic studies
- Anthrax overview
- Anthrax pathophysiology
- Anthrax physical examination
- Anthrax prevention
- Anthrax risk factors
B
- Botulism (patient information)
- Botulism case study one
- Botulism future or investigational therapies
- Botulism overview
- Botulism/Future or Investigational Therapies
- Brucellosis (patient information)
- Brucellosis Biological warfare
- Brucellosis case study one
- Brucellosis chest x ray
- Brucellosis diagnostic criteria
- Brucellosis future or investigational therapies
- Brucellosis Imaging
C
- Cholera case study one
- Cholera future or investigational therapies
- Cholera vaccine
- Coccidioidomycosis
- Coccidioidomycosis (patient information)
- Coccidioidomycosis case study one
- Coccidioidomycosis chest x ray
- Coccidioidomycosis cost-effectiveness of therapy
- Coccidioidomycosis CT
- Coccidioidomycosis differential diagnosis
- Coccidioidomycosis epidemiology and demographics
- Coccidioidomycosis future or investigational therapies
- Coccidioidomycosis historical perspective
- Coccidioidomycosis history and symptoms
- Coccidioidomycosis laboratory tests
- Coccidioidomycosis medical therapy
- Coccidioidomycosis MRI
- Coccidioidomycosis natural history
- Coccidioidomycosis other diagnostic studies
- Coccidioidomycosis other imaging findings
- Coccidioidomycosis overview
- Coccidioidomycosis pathophysiology
- Coccidioidomycosis physical examination
- Coccidioidomycosis primary prevention
- Coccidioidomycosis risk factors
- Coccidioidomycosis screening
- Coccidioidomycosis secondary prevention
- Coccidioidomycosis surgery
D
- Dengue fever
- Dengue fever (patient information)
- Dengue fever case study one
- Dengue fever classification
- Dengue fever cost-effectiveness of therapy
- Dengue fever differential diagnosis
- Dengue fever epidemiology and demographics
- Dengue fever future or investigational therapies
- Dengue fever historical perspective
- Dengue fever history and symptoms
- Dengue fever laboratory tests
- Dengue fever medical therapy
- Dengue fever natural history, complications and prognosis
- Dengue fever other diagnostic studies
- Dengue fever other imaging findings
- Dengue fever overview
- Dengue fever pathophysiology
- Dengue fever physical examination
- Dengue fever primary prevention
- Dengue fever risk factors
- Dengue fever secondary prevention
E
- Ebola
- Ebola (patient information)
- Ebola air medical transport
- Ebola algorithm for the evaluation of the returned traveler
- Ebola case definition
- Ebola case study one
- Ebola checklists
- Ebola classification
- Ebola cost-effectiveness of therapy
- Ebola differential diagnosis
- Ebola emergency department evaluation
- Ebola emergency medical services checklist
- Ebola epidemiology and demographics
- Ebola future or investigational therapies
- Ebola healthcare coalition checklist
- Ebola healthcare facility checklist
- Ebola healthcare provider checklist
- Ebola historical perspective
- Ebola history and symptoms
- Ebola hospital preparedness
- Ebola laboratory tests
- Ebola medical therapy
- Ebola monitoring and movement of persons following exposure
- Ebola natural history
- Ebola other diagnostic studies
- Ebola overview
- Ebola pathophysiology
- Ebola physical examination
- Ebola postmortem care
- Ebola primary prevention
- Ebola risk factors
- Ebola screening
- Ebola virus
L
- Lassa fever
- Lassa fever (patient information)
- Lassa fever case study one
- Lassa fever cost-effectiveness of therapy
- Lassa fever differential diagnosis
- Lassa fever epidemiology and demographics
- Lassa fever future or investigational therapies
- Lassa fever historical perspective
- Lassa fever history and symptoms
- Lassa fever laboratory findings
- Lassa fever medical therapy
- Lassa fever natural history, complications and prognosis
- Lassa fever other diagnostic studies
- Lassa fever overview
- Lassa fever pathophysiology
- Lassa fever physical examination
- Lassa fever primary prevention
- Lassa fever risk factors
- Lassa virus
R
T
- T-2 mycotoxin
- Tularemia
- Tularemia (patient information)
- Tularemia case study one
- Tularemia classification
- Tularemia cost-effectiveness of therapy
- Tularemia differential diagnosis
- Tularemia epidemiology and demographics
- Tularemia future or investigational therapies
- Tularemia historical perspective
- Tularemia history and symptoms
- Tularemia laboratory findings
- Tularemia medical therapy
- Tularemia natural history, complications and prognosis
- Tularemia other diagnostic studies
- Tularemia overview
- Tularemia pathophysiology
- Tularemia physical examination
- Tularemia primary prevention
- Tularemia risk factors
- Tularemia secondary prevention
- Typhus
- Typhus (patient information)
- Typhus case study one
- Typhus causes
- Typhus chest x ray
- Typhus classification
- Typhus cost-effectiveness of therapy
- Typhus differential diagnosis
- Typhus epidemiology and demographics
- Typhus future or investigational therapies
- Typhus historical perspective
- Typhus history and symptoms
- Typhus laboratory findings
- Typhus medical therapy
- Typhus natural history, complications and prognosis
- Typhus other diagnostic studies
- Typhus overview
- Typhus pathophysiology
- Typhus physical examination
- Typhus primary prevention
- Typhus risk factors
- Typhus secondary prevention